Can a targeted chemo procedure stop liver cancer from coming back after surgery?

NCT ID NCT07417397

Recruiting now Disease control Sponsor: Guangxi Medical University Source: ClinicalTrials.gov ↗

First seen Feb 21, 2026 · Last updated May 15, 2026 · Updated 12 times

Summary

This study is for people with liver cancer who have had surgery to remove their tumor but are at high risk of the cancer returning. Researchers want to see if adding a procedure called TACE (which delivers chemotherapy directly to the liver) after surgery can help keep the cancer away longer. About 442 participants will be randomly assigned to receive either TACE or just regular follow-up care. The main goal is to compare how long each group stays cancer-free.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Guangxi Medical University Cancer Hospital
RECRUITING

Nanning, 530021, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

ADJUVANT HEPATOCELLULAR CARCINOMA TRANSARTERIAL CHEMOEMBOLIZATION TRANSARTERIAL CHEMOEMBOLIZATION